So the MRI results came back... totally normal. They didn't find anything. They want to schedule him for yet ANOTHER endoscopy. I don't understand how they can not know where this cancer is. We are both so frustrated now.
That is good news, it seems to me, because if it was large or widespread, they probably would have seen something. Frustrating, though. Did they talk about a PETscan too? I looked up a couple things and found this ↓, I had never heard of this type of cancer before, tbh.
"Advances in nuclear medicine imaging, also known as molecular imaging, has improved diagnostic and treatment paradigms in patients with neuroendocrine tumors. This is because of its ability to not only identify sites of disease but also characterize them. Neuronedocrine tumours express somatostatin receptors providing a unique target for imaging. Octreotide is a synthetic modifications of somatostatin with a longer half-life. OctreoScan, also called somatostatin receptorscintigraphy (SRS or SSRS), utilizes intravenously administered octreotide that is chemically bound to a radioactive substance, often indium-111, to detect larger lesions with tumor cells that are avid for octreotide.
Somatostatin receptor imaging can now be performed with positron emission tomography (PET) which offers higher resolution, three-dimensional and more rapid imaging. Gallium-68 receptor PET-CT is much more accurate than an OctreoScan.
[53]Imaging with fluorine-18 fluorodeoxyglucose (FDG) PET is also valuable to image neuroendocrine tumors.[54] This scan is performed by injected radioactive sugar intravenously. Tumors that grow more quickly use more sugar. Using this scan, the aggressiveness of the tumor can be visualised.The combination of somatostatin receptor and FDG PET imaging is able to quantify somatostatin receptor cell surface (SSTR) expression and glycolytic metabolism, respectively.[54] The ability to perform this as a whole body study is highlighting the limitations of relying on histopathology obtained from a single site. This is enabling better selection of the most appropriate therapy for an individual patient."
http://en.m.wikipedia.org/wiki/Neuroendocrine_tumor